Despite the widespread use of caffeine as a central nervous stimulant, the central pharmacodynamic properties of the drug have not yet been conclusively evaluated in humans. The present study was undertaken to assess the acute effects of caffeine on measures of topographical quantitative electroencephalogram (EEG) in normal subjects. Ten healthy male volunteers (mean age B SD 25 B 4 years) received placebo and 200 mg of caffeine as powder with oral water solution (caffeine amount = 2 cups of coffee) under randomized, double-blind crossover conditions on two different occasions. Before administration and 30 min afterwards, a 17-channel quantitative EEG was recorded during relaxation with eyes open and closed (15 min each). Caffeine caused a significant reduction of total EEG power at fronto-parieto-occipital and central electrode positions of both hemispheres when the subjects kept their eyes open. Absolute power of the slow and fast alpha and slow beta activities was diminished in various regions of the brain (p ! 0.05). The effect was more pronounced with the subjects keeping their eyes open than with eyes closed. It can be concluded that quantitative EEG is a sensitive method to assess the effects of psychostimulants on the human brain. Therefore, in pharmaco-EEG studies, environmental factors such as caffeine have to be excluded.
Introduction
Caffeine (1,3,7-trimethylxanthine), a component of tea, coffee and soft drinks, is the most widely used psychoactive agent in the world [1] . Studies in North America show a daily intake of approximately 200 mg per adult [2] . The acute administration of this dose increases alertness, stimulates attention and restores performance degraded by factors such as fatigue and boredom [3] . However, a wide variation in the behavioral effects of caffeine has been demonstrated in humans receiving doses of this magnitude [4] . The changes in brain state brought about by caffeine are generally described in terms of increases in excitatory processes, reduced inhibitory processes and/or increased availability of energy. The global picture of excitatory effects has correlates at the global-physiologic level manifest in the spontaneous background electroencephalogram (EEG). Topographical quantitative EEG measures provide a neurophysiological assessment of brain activity that correlates with behavior [5] . EEG power spectrum variables have been used for classification of psychotropic drugs such as stimulants, antidepressants Siepmann and tranquilizers [6] . However, previous studies on the effect of caffeine on EEG are inconsistent regarding the direction of the effect of caffeine on EEG power. Kenemans and Lorist [7] as well as Dimpfel et al. [8] found reductions in power, whereas Hasenfratz and Bättig [9] and Etevenon et al. [10] found increases. Difficulties in comparing the power shifts across studies are due to the circumstance that some experiments compare baseline effects with a single dose while others compare changes across a range of caffeine doses. The present study was undertaken to rigorously examine the effects of 200 mg of caffeine given as a single dose to healthy subjects on the CNS-relevant variables of topographical quantitative EEG.
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Subjects and Methods
Subjects
Ten healthy male subjects aged 22-33 years (mean B SD 25 B 4 years), weighing between 59 and 84 kg (71 B 8 kg) and 171-184 cm (179 B 5 cm) in height were enrolled in the study. The study was conducted according to the Declaration of Helsinki (Sommerset West Amendment 1996). Written informed consent from the subjects and approval from the Hospital Ethics Committee (Dresden, Germany) were obtained. The subjects were moderate users of caffeine. This means they consumed 1-2 cups of coffee per day. They were included after a standard physical examination, clinical laboratory tests and a 12-lead ECG.
Protocol
The subjects were not allowed to smoke or to consume alcoholic or caffeine-containing beverages for 10 h before and during the trial. They had to have been free of medication for at least 14 days. After an overnight fast, the subjects presented themselves in the morning. They received 200 mg of caffeine orally as powder with 150 ml of water solution as well as placebo (glucose) on two different occasions under randomized, double-blind, crossover conditions. All recordings took place in a quiet room with the subjects sitting in a comfortable chair.
Quantitative EEG was recorded before and 30 min after ingestion of caffeine and placebo with the subjects keeping their eyes open and closed for periods of 15 min each. Heart rate was monitored by hand at the end of each period.
Topographical Quantitative EEG
Data acquisition and signal analysis followed the guidelines of the International Pharmaco-EEG Group [11] . Details of the methods have been described elsewhere [12] . Briefly, the EEG was recorded bipolarly from 17 surface electrodes by means of an electrode cap according to the standard 10-20 system with C z as physical reference. EEG signals were amplified with a Cateem ® apparatus (Proscience, Linden, Germany) and sampled at a rate of 512 Hz and 12 bit. ECG and electrooculogram were recorded simultaneously. Arti-facts were rejected automatically. Analog signals were displayed on a separate monitor for visual control. The signals of all EEG electrodes were frequency analyzed with the fast Fourier transformation, based on sweeps of 4-second data epochs by means of a Hanning window. In the resulting spectrum, six frequency bands were defined: delta (1. 
Statistical Analysis
All data were analyzed using the Sigma Stat software package (Jandel, San Rafael, Calif., USA). Evaluation was done with a oneway ANOVA procedure for repeated measurements. Friedman repeated-measures ANOVA on ranks was performed when values were not normally distributed. If significant, Student-Newman-Keuls post hoc tests were used for comparisons between treatment conditions. Statistical significance was accepted at p ! 0.05.
Results
After administration of caffeine, total power in the quantitatively analyzed EEG was significantly reduced at frontal (F z , F 3 , F 4 ), central (C z , C 3 , C 4 ), temporal (T 6 ), parietal (P 3 , P 4 ) and occipital (O 1 , O 2 ) electrode positions when the subjects kept their eyes open (p ! 0.05; table 1). A trend in the same direction was seen with eyes closed in frontal (F z , F 3 , F 4 , F 7 ), central (C z , C 3 , C 4 ), temporal (T 3 , T 4 , T 6 ), parietal (P 3 , P 4 , P z ) and occipital leads (O 2 ), although statistical significance was not reached (p 1 0.05). As shown in figures 1 and 2, caffeine significantly reduced absolute power in the slow and fast alpha (alpha 1 and alpha 2 ) as well as the slow beta (beta 1 ) frequency ranges at various electrode positions under the eyes open condition. Alpha power was not significantly affected, whereas beta 1 power was reduced when the subjects kept their eyes closed. Theta and delta activities were diminished in a few leads under both conditions. No concomitant changes in heart rate were noted. No specific topographical distribution of the EEG changes was noted. However, the reduction of alpha power was accentuated in frontal and occipital regions of both hemispheres ( fig. 1, 2) .
Discussion
This study confirms the findings of a number of recent studies that caffeine attenuates total power (1.5-35 Hz) in the quantitatively analyzed EEG [7, 8, 13, 14] . The effect was observed at frontal, parietal, occipital and central electrode positions. All frequency ranges were concerned, but the effect was most pronounced in the slow and fast alpha bands with the subjects keeping their eyes open. The lack of a specific topographical pattern of the EEG changes may be due to the limited topographical resolution of pharmaco-EEG. The decrease in the alpha frequency ranges is consistent with the notion that caffeine increases cortical activation, excitability and/or arousal [15] . Attenuation of alpha as well as total power has also been reported with other psychostimulants such as amphetamine [13, 16] . Contrasting reports in the literature of minimal or no effects [17, 18] or power-increasing effects of caffeine [9, 10] seem to be due to differences in baseline, dose and even recording conditions, e.g. resting EEG versus vigilance-controlled EEG. Although not the focus of the present study, other studies have shown that withdrawal from caffeine results in an increase in EEG power which can be reversed by administration of caffeine [19, 20] . The primary mechanism of action of caffeine is adenosine receptor antagonism, by blocking cAMP formation [21] . Since adenosine, a neuromodulator released during normal cortical metabolic activity, acts to depress synaptic activity and inhibit neurotransmitter release, consumption of caffeine acts as a powerful moderator of this function. In addition, caffeine ingestion has also been associated with increases in the rate of catecholamine synthesis [15] , which is significant with respect to the stimulant properties of caffeine, because of the role that the reticular system plays in the modulation of cortical arousal. The stimulant effects of caffeine are associated with changes in the local rates of cerebral energy metabolism.
Experiments in rats show that acute doses of caffeine of 10 mg/kg increase cerebral glucose utilization in monoaminergic cell groupings like the substantia nigra and ventral tegmental area, which are rich in dopamine, medial and dorsal raphe nuclei, which contain serotonin, and the locus ceruleus, which is rich in noradrenaline [22] . Caffeine increases the rates of energy metabolism in the structures of the extrapyramidal motor system and in numerous thalamic nuclei and limbic areas such as the hippocampus [23] . These local increases of cerebral glucose utilization which are involved in the sleep/wake cycle correlate with behavioral modifications as mentioned above [15] . Caffeine induces a decrease in local cerebral blood flow, mainly in the areas where it increases metabolism, i.e. in monoaminergic cell groupings, in the limbic system and in the thalamus [24] . Contrary to the majority of pharmacological agents to which humans are frequently exposed, caffeine has the property of inducing cerebral hypoperfusion accompanied by a simultaneous increase in glucose utilization. Like other methylxanthines, e.g. theophylline, caffeine thus seems to modify the regulating mechanism between blood flow and cerebral metabolism in the CNS. Although this mechanism is not yet well understood, adenosine, with which methylxanthines compete, is known to be one of the modulators of the regulation of the relationship of blood flow to metabolism in the central nervous system [25] . It is highly speculative to extend conclusions from experiments in animals such as rats to humans. Parameters of quantitative EEG can be employed to monitor drug effects on cerebral blood flow and metabolism in humans [26] . Vasodilating agents such as glyceroltrinitrate increase EEG power, whereas vasoconstricting agents such as indomethacin decrease EEG power in healthy subjects [27, 28] . In the present study, 200 mg of caffeine, which is comparable to the caffeine amount in 2 cups of coffee, caused a significant attenuation of EEG power in various brain regions. It has been shown that cerebral metabolism and EEG power are inversely related in normal subjects [29] . Caffeine acts as a vasoconstrictor. It subsequently decreases cerebral voltage. Usage of caffeine may affect cerebral functioning more profoundly than has previously been suspected. While quantitative EEG is being increasingly used to study neurophysiologic effects of various substances, caffeine usage is not currently considered or controlled in such investigations. Our findings suggest that usage of relatively small amounts of caffeine may have a significant effect on cerebral voltage. Of particular importance would be studying chronic caffeine use and evaluation of frequency changes.
In conclusion, single doses of 200 mg of caffeine attenuate EEG power at various electrode positions. The effect is most pronounced in the alpha bands.
